Predict your next investment

Corporation
HEALTHCARE | Drug Development
themedicinescompany.com

See what CB Insights has to offer

Founded Year

1996

Stage

Acq - P2P | Acquired

Total Raised

$100.78M

Valuation

$0000 

About The Medicines Company

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. The company's vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care.

The Medicines Company Headquarter Location

8 Sylvan Way

Parsippany, New Jersey, 07054,

United States

973-290-6000

Latest The Medicines Company News

Oral Anticoagulants Market Size, Global industry analysis, Recent Developments, Opportunities and Forecast by 2028 | The Medicines Company, Urigen Pharmaceuticals, Boehringer Ingelheim, BMS & so on…

May 12, 2021

| The Medicines Company, Urigen Pharmaceuticals, Boehringer Ingelheim, BMS & so on… Oral Anticoagulants market players – The Medicines Company, Urigen Pharmaceuticals, Boehringer Ingelheim, BMS, among others represent the global Oral Anticoagulants market . The market study depicts an extensive analysis of all the players running in the Oral Anticoagulants market report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Oral Anticoagulants market report. Future Market Insights, in its latest business report, elaborates on the current situation of the global Oral Anticoagulants market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects. Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-6587 Proximal deep vein thrombosis (DVT) Arterial and venous thrombosis Others On the basis of Distribution Channels, the global Oral Anticoagulants market report covers the key segments, such as Hospital Pharmacies What key insights does the Oral Anticoagulants market research provide? Historical and current year revenue of related Oral Anticoagulants market players analyzed at the regional level. One by one company profile of prominent stakeholders. Analysis of the Oral Anticoagulants market size on the basis of product type and end-use type. Accurate Oral Anticoagulants market forecast in terms of value and volume in numbers and percentages. Demand prospect of each segment covered in the report. Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-6587 How the market for Oral Anticoagulants is expected to shape in the coming ten years? What strategies are the Oral Anticoagulants market vendors implementing to stay ahead of their rivals? Why are consumers shifting towards alternative Oral Anticoagulants products? What innovative technologies are the Oral Anticoagulants players using to get an edge over their rivals? What are the restraints affecting the growth of the global Oral Anticoagulants market? The Oral Anticoagulants market study considers the following years to project the overall market growth: History Year: 2014 – 2018 Modern technologies, such as artificial intelligence, to provide updated industry trends. Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective. Interaction with research scientists and development heads to understand the nature of the market more precisely. Three-step quality check process – Data collection, triangulation, and validation. 24/7 availability of services. Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape Folliculotropic Mycosis Fungoides Treatment Market  FMI’s analysis gives an insight into key market trends, strategies, regional players and various segments on the basis of form, type, application and region. Nose Reconstruction Market  Find insights into global market scenario and segmentation on the basis of ingredients, application, source and region. Porokeratosis treatment Market  FMI’s report highlights parent market trends and strategies in the market with segments and dynamics through the forecast period. About us  Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI  is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest  market research reports  and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact us Jumeirah Lakes Towers, Dubai, PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2021.4.7.1 You are leaving PharmiWeb.com Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com. PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information. Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely. If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly. Continue

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing The Medicines Company

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

The Medicines Company is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

The Medicines Company Patents

The Medicines Company has filed 60 patents.

The 3 most popular patent topics include:

  • G protein coupled receptors
  • Pharmaceutical industry
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/6/2014

8/31/2021

Calcium channel blockers, Carboxylate esters, Dihydropyridines, Food additives, Amines

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/6/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/31/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Calcium channel blockers, Carboxylate esters, Dihydropyridines, Food additives, Amines

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.